Impact of prior smoking exposure and COPD comorbidity on treatment response to monoclonal antibodies in patients with severe asthma

ERJ Open Res. 2021 Aug 16;7(3):00190-2021. doi: 10.1183/23120541.00190-2021. eCollection 2021 Jul.

Authors

Heba Morobeid^{1

2}, Carmen Pizarro^{1

2}, Leonie Biener¹, Gudrun Ulrich-Merzenich³, Daniel Kütting⁴, Georg Nickenig¹, Dirk Skowasch¹

Affiliations

¹ Dept of Internal Medicine II - Pneumology/Cardiology, University Hospital Bonn, Bonn, Germany.
² These authors contributed equally.
³ Dept of Internal Medicine III - Oncology, University Hospital Bonn, Bonn, Germany.
⁴ Dept of Radiology, University Hospital Bonn, Bonn, Germany.

Abstract

Patients suffering from severe asthma may benefit from an antibody treatment irrespective of their status as an ex-smoker https://bit.ly/3fYC8tC.

Copyright ©The authors 2021.